S&P 500   4,320.10 (+0.00%)
DOW   33,857.88 (-0.31%)
QQQ   356.96 (-0.27%)
AAPL   174.98 (+0.11%)
MSFT   315.16 (-0.58%)
META   296.95 (-0.71%)
GOOGL   129.88 (-0.28%)
AMZN   130.46 (+1.04%)
TSLA   242.78 (-0.86%)
NVDA   420.09 (+0.96%)
NIO   8.35 (-2.11%)
BABA   86.75 (-1.76%)
AMD   95.83 (-0.38%)
T   14.92 (-1.32%)
F   12.62 (+1.53%)
MU   68.53 (-0.51%)
CGC   0.93 (+10.32%)
GE   111.47 (+0.20%)
DIS   80.71 (-0.66%)
AMC   8.08 (+6.04%)
PFE   32.63 (-0.18%)
PYPL   58.16 (+0.48%)
NFLX   381.83 (+0.53%)
S&P 500   4,320.10 (+0.00%)
DOW   33,857.88 (-0.31%)
QQQ   356.96 (-0.27%)
AAPL   174.98 (+0.11%)
MSFT   315.16 (-0.58%)
META   296.95 (-0.71%)
GOOGL   129.88 (-0.28%)
AMZN   130.46 (+1.04%)
TSLA   242.78 (-0.86%)
NVDA   420.09 (+0.96%)
NIO   8.35 (-2.11%)
BABA   86.75 (-1.76%)
AMD   95.83 (-0.38%)
T   14.92 (-1.32%)
F   12.62 (+1.53%)
MU   68.53 (-0.51%)
CGC   0.93 (+10.32%)
GE   111.47 (+0.20%)
DIS   80.71 (-0.66%)
AMC   8.08 (+6.04%)
PFE   32.63 (-0.18%)
PYPL   58.16 (+0.48%)
NFLX   381.83 (+0.53%)
S&P 500   4,320.10 (+0.00%)
DOW   33,857.88 (-0.31%)
QQQ   356.96 (-0.27%)
AAPL   174.98 (+0.11%)
MSFT   315.16 (-0.58%)
META   296.95 (-0.71%)
GOOGL   129.88 (-0.28%)
AMZN   130.46 (+1.04%)
TSLA   242.78 (-0.86%)
NVDA   420.09 (+0.96%)
NIO   8.35 (-2.11%)
BABA   86.75 (-1.76%)
AMD   95.83 (-0.38%)
T   14.92 (-1.32%)
F   12.62 (+1.53%)
MU   68.53 (-0.51%)
CGC   0.93 (+10.32%)
GE   111.47 (+0.20%)
DIS   80.71 (-0.66%)
AMC   8.08 (+6.04%)
PFE   32.63 (-0.18%)
PYPL   58.16 (+0.48%)
NFLX   381.83 (+0.53%)
S&P 500   4,320.10 (+0.00%)
DOW   33,857.88 (-0.31%)
QQQ   356.96 (-0.27%)
AAPL   174.98 (+0.11%)
MSFT   315.16 (-0.58%)
META   296.95 (-0.71%)
GOOGL   129.88 (-0.28%)
AMZN   130.46 (+1.04%)
TSLA   242.78 (-0.86%)
NVDA   420.09 (+0.96%)
NIO   8.35 (-2.11%)
BABA   86.75 (-1.76%)
AMD   95.83 (-0.38%)
T   14.92 (-1.32%)
F   12.62 (+1.53%)
MU   68.53 (-0.51%)
CGC   0.93 (+10.32%)
GE   111.47 (+0.20%)
DIS   80.71 (-0.66%)
AMC   8.08 (+6.04%)
PFE   32.63 (-0.18%)
PYPL   58.16 (+0.48%)
NFLX   381.83 (+0.53%)
NASDAQ:TTOO

T2 Biosystems (TTOO) Price Target & Analyst Ratings

$0.21
-0.04 (-15.47%)
(As of 11:03 AM ET)
Compare
Today's Range
$0.21
$0.25
50-Day Range
$0.09
$0.59
52-Week Range
$0.05
$5.72
Volume
34.23 million shs
Average Volume
48.56 million shs
Market Capitalization
$71.62 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$2.50

T2 Biosystems Consensus Rating and Price Target (2023)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Analyst Rating

Hold
Based on 1 Analyst Ratings

Consensus Analyst Price Target

$2.50
1,064.42% Upside
High Prediction$2.50
Average Prediction$2.50
Low Prediction$2.50
TypeCurrent
9/25/22 to 9/25/23
1 Month Ago
8/26/22 to 8/26/23
3 Months Ago
6/27/22 to 6/27/23
1 Year Ago
9/25/21 to 9/25/22
Consensus Rating
Hold
Hold
Hold
Hold
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
0 Buy rating(s)
0 Buy rating(s)
0 Buy rating(s)
1 Buy rating(s)
Hold
1 Hold rating(s)
1 Hold rating(s)
3 Hold rating(s)
2 Hold rating(s)
Sell
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
Consensus Price Target$2.50$2.50$2.50$55.00
Predicted Upside1,064.42% Upside-1.96% Downside-1.96% Downside144.75% Upside
Get T2 Biosystems Upgrade and Downgrade Alerts

Sign-up to receive the latest news and ratings for TTOO and its competitors with MarketBeat's FREE daily newsletter.


TTOO Analyst Ratings By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

TTOO Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

T2 Biosystems Stock vs. The Competition

TypeT2 BiosystemsMedical CompaniesS&P 500
Consensus Rating Score
2.00
2.66
2.49
Consensus RatingHoldModerate BuyHold
Predicted Upside1,064.42% Upside1,329.42% Upside628.67% Upside
News Sentiment RatingNeutral News
Positive News
Positive News

Historical Target Prices and Ratings

DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
10/14/2022Canaccord Genuity Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingBuy ➝ Hold
(Data available from 9/25/2018 forward. View 10+ years of historical ratings with our analyst ratings screener.)












TTOO Price Target - Frequently Asked Questions

What is T2 Biosystems's consensus rating and price target?

According to the issued ratings of 1 analysts in the last year, the consensus rating for T2 Biosystems stock is Hold based on the current 1 hold rating for TTOO. The average twelve-month price prediction for T2 Biosystems is $2.50 with a high price target of $2.50 and a low price target of $2.50. Learn more on TTOO's analyst rating history.

Do Wall Street analysts like T2 Biosystems more than its competitors?

Analysts like T2 Biosystems less than other Medical companies. The consensus rating for T2 Biosystems is Hold while the average consensus rating for medical companies is Moderate Buy. Learn more on how TTOO compares to other companies.

Does T2 Biosystems's stock price have much downside?

According to analysts, T2 Biosystems's stock has a predicted downside of -1.96% based on their 12-month price targets.


Stock Ratings Reports and Tools

This page (NASDAQ:TTOO) was last updated on 9/25/2023 by MarketBeat.com Staff

My Account -